PULMONARY FIBROSIS FOUNDATION

Serial Number 88379949
Registration 6187739
700

Registration Progress

Application Filed
Apr 10, 2019
Under Examination
Approved for Publication
Aug 18, 2020
Published for Opposition
Aug 18, 2020
Registered
Nov 3, 2020

Attorney Assistance

Section 8 Declaration Due (Principal Register) (Based on registration date 20201103)
Due: Nov 03, 2026 291 days

Trademark Image

PULMONARY FIBROSIS FOUNDATION

Basic Information

Serial Number
88379949
Registration Number
6187739
Filing Date
April 10, 2019
Registration Date
November 3, 2020
Published for Opposition
August 18, 2020
Drawing Code
5

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 3, 2020
Registration
Registered
Classes
016 035 036 041
+2 more

Rights Holder

Pulmonary Fibrosis Foundation

99
Address
Suite 500
230 East Ohio Street
Chicago, IL 60611

Ownership History

Pulmonary Fibrosis Foundation

Original Applicant
99
Chicago, IL

Pulmonary Fibrosis Foundation

Owner at Publication
99
Chicago, IL

Pulmonary Fibrosis Foundation

Original Registrant
99
Chicago, IL

Legal Representation

Attorney
J. Kevin Grogan

USPTO Deadlines

Next Deadline
291 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20201103)
Due Date
November 03, 2026
Grace Period Ends
May 03, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description Documents
Nov 3, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Nov 3, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 18, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 18, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 29, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 15, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 15, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jul 15, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jul 15, 2020 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jul 15, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jul 14, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 13, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 13, 2020 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Jan 14, 2020 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Jan 14, 2020 GNFR O FINAL REFUSAL E-MAILED Loading...
Jan 14, 2020 CNFR R FINAL REFUSAL WRITTEN Loading...
Dec 23, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 23, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 23, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 21, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 21, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 21, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 20, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 27, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 13, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 016
Providing indirect healthcare materials, namely, printed educational materials in the field of pulmonary fibrosis to help patients understand and treat pulmonary fibrosis
First Use Anywhere: 20111000
First Use in Commerce: 20111000
Class 035
Promoting public awareness of the need for a cure for pulmonary fibrosis; association services, namely promoting public interest in research, study, and training in the field of pulmonary fibrosis
First Use Anywhere: 20111000
First Use in Commerce: 20111000
Class 036
Charitable fund-raising services; providing research grants for study and training in the field of pulmonary fibrosis and related disease research
First Use Anywhere: 20111000
First Use in Commerce: 20111000
Class 041
Providing online non-downloadable educational materials in the nature of online newsletters in the field of pulmonary fibrosis to help patients to understand and treat pulmonary fibrosis and related diseases
First Use Anywhere: 20111000
First Use in Commerce: 20111000
Class 044
Providing medical information with respect to pulmonary fibrosis
First Use Anywhere: 20111000
First Use in Commerce: 20111000
Class 045
Providing patient advocacy services for individuals affected by pulmonary fibrosis
First Use Anywhere: 20111000
First Use in Commerce: 20111000

Additional Information

Design Mark
The mark consists of the wording "PULMONARY FIBROSIS FOUNDATION" in a stylized font. The letter "P" in the word "PULMONARY" is capitalized, with the remaining letters lower case. The letter "F" in the word "FIBROSIS" is capitalized, with the remaining letters lower case. All of the letters in the word "FOUNDATION" are capitalized. The wording "PULMONARY FIBROSIS" appears above the word "FOUNDATION".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
016 035 036 041 044 045

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"FOUNDATION"